Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital (SCREENING)

Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital (SCREENING Study)

The main objectives are:

• To establish the prevalence of deep venous thrombosis through ultrasonography in Patients infected with COVID-19 admitted to hospital.
• To identify patients with higher risk of deep venous thrombosis.

Study Overview

• Status: Completed
• Conditions: COVID-19

• Study Type: Observational
• Enrollment (Actual): 2497

Contacts and Locations

Study Locations

• Spain
  • Barcelona
    • Badalona, Barcelona, Spain, 08916
      • Manuel Monreal

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Patients infected with COVID-19 admitted to hospital

Description

Inclusion Criteria:

• Patients infected with COVID-19.
• Admission to hospital.

Exclusion Criteria:

• Patients treated with ECMO (Extracorporeal membrane oxygenation).

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
VTE events and complications	Study endpoints are clinically recognized (and objectively confirmed) recurrences of VTE, major and minor bleeding complications, and death.	30 days

Collaborators and Investigators

• Sponsor: Manuel Monreal
• Investigators: Study Chair: Manuel Monreal, Germans Trias i Pujol Hospital

Study record dates

Study Major Dates

• Study Start (Actual): April 13, 2020
• Primary Completion (Actual): October 13, 2020
• Study Completion (Actual): October 13, 2020

Study Registration Dates

• First Submitted: May 7, 2020
• First Submitted That Met QC Criteria: May 7, 2020
• First Posted (Actual): May 8, 2020

Study Record Updates

• Last Update Posted (Actual): December 14, 2020
• Last Update Submitted That Met QC Criteria: December 11, 2020
• Last Verified: December 1, 2020

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections; Respiratory Tract Infections; Respiratory Tract Diseases; Pneumonia, Viral; Pneumonia; Lung Diseases; COVID-19
• Other Study ID Numbers: SCREENING042020

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No